ED
AABA

Exane Derivatives’s Altaba Inc AABA Stock Holding History

Exane Derivatives’s Portfolio AABA Stock Details AABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-663
Closed -$12.9K – 715
2019
Q3 		$12.9K Hold
663
– – ﹤0.01% 416
2019
Q2 		$46K Buy
+663
New +$46.4K 0.01% 395
2019
Q1 		– Sell
-663
Closed -$38.4K – 724
2018
Q4 		$38.4K Hold
663
– – 0.01% 388
2018
Q3 		$45.1K Hold
663
– – 0.01% 375
2018
Q2 		$48.5K Hold
663
– – 0.01% 388
2018
Q1 		$48.1K Hold
663
– – 0.01% 354
2017
Q4 		$46.3K Hold
663
– – 0.01% 347
2017
Q3 		$43.9K Buy
+663
New +$40.7K 0.01% 316

Other funds holding AABA

CWM
CIBC World Markets New York $20.8B AUM
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAS
Wesleyan Assurance Society Birmingham, United Kingdom $1.69B AUM 28.38% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
SIG
Sky Investment Group Hartford, Connecticut $637M AUM 20.14% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
BAM
Barrett Asset Management New York $2.39B AUM 14.06% 1-Year Est. Return
QAM
QCI Asset Management Pittsford, New York $1.72B AUM 25.41% 1-Year Est. Return

Exane Derivatives's AABA Position: Q4 2019 in Review

Exane Derivatives sold out of Altaba Inc (AABA) in Q4 2019, closing a stake of 663 shares — an estimated $12.9K sold.

Exane Derivatives first reported a position in AABA in Q3 2017 and held it in 8 quarters. The position peaked at $48.5K in Q2 2018. 13 funds tracked by Wall St. Rank hold AABA as of Q4 2019.

  • Exane Derivatives reported no remaining Altaba Inc position as of Q4 2019 after selling out during the quarter.
  • Exane Derivatives sold 663 Altaba Inc shares in Q4 2019, an estimated $12.9K.
  • Exane Derivatives first reported a position in Altaba Inc in Q3 2017 and held it in 8 quarters.
  • Exane Derivatives's Altaba Inc position peaked at $48.5K in Q2 2018.
  • 13 funds tracked by Wall St. Rank held Altaba Inc as of Q4 2019.

Based on Exane Derivatives's 13F filing for Q4 2019, filed 22 Jan 2020.